Subutex is a brand name for buprenorphine hydrochloride, a medication primarily used in opioid use disorder (OUD) treatment. It’s a partial opioid agonist, meaning it activates opioid receptors in the brain but to a lesser extent than full agonists like heroin or oxycodone, helping to reduce cravings and withdrawal symptoms without producing a strong “high.”

Key Facts and Uses

Primary Use: Medication-assisted treatment (MAT) for opioid addiction. It’s often prescribed as part of a comprehensive program including counseling.
Form: Sublingual tablets (dissolved under the tongue). Common strengths: 2 mg, 8 mg.
How It Works:

Aspect	Description
Mechanism	Binds to mu-opioid receptors with high affinity, displacing full opioids like fentanyl or morphine, blocking their effects.
Ceiling Effect	Limits euphoria and respiratory depression risk compared to full opioids.
Duration	Effects last 24–72 hours, allowing once-daily dosing.

Comparison to Similar Drugs:

Drug	Key Difference
Suboxone	Subutex + naloxone (opioid antagonist) to deter misuse (e.g., injection). Subutex lacks naloxone, so it’s riskier for diversion.
Methadone	Full agonist; requires clinic dispensing. Subutex can be prescribed for home use.
Sublocade	Long-acting buprenorphine injection (monthly).

Dosage and Administration (Typical Adult)

Induction: Start with 2–4 mg on Day 1, up to 8–16 mg/day.
Maintenance: 8–24 mg/day, adjusted based on response.
Evidence: Supported by studies like the 2009 NEJM trial showing buprenorphine reduces illicit opioid use by 50–70% vs. placebo.

Side Effects and Risks

Common (Mild)	Serious
Headache, nausea, constipation, sweating	Respiratory depression (rare, but fatal if mixed with benzos/alcohol), precipitated withdrawal if taken too early in detox, dependence.

Overdose Risk: Lower than full opioids, but still possible. Naloxone reverses it.
Pregnancy: Category C; used safely in neonatal abstinence syndrome prevention (evidence from MOTHER study).

Legal and Availability

Controlled Substance: Schedule III in the US (DEA).
Prescription: Requires special waiver (e.g., DATA 2000 for physicians). Not for pain relief primarily—use Belbuca or generics for that.
Street Context: Often diverted/abused sublingually or IV. Street prices: $1–2/mg (per DEA reports).

Warnings

Do not use with: Alcohol, sedatives, or other opioids—increases overdose risk (CDC data: 30% of opioid ODs involve benzos).
Tapering: Abrupt stop causes withdrawal; taper slowly.
Source: FDA-approved (1990s); info from FDA label, NIH, SAMHSA guidelines.

If you’re seeking it for treatment, consult a doctor or SAMHSA hotline (1-800-662-HELP). Not medical advice—always verify with a professional. Need more details (e.g., interactions, studies)? Ask!

All Departments

+44 7482 592798